We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+13.78%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.65B
AUM Growth
+$261M
Cap. Flow
+$78.3M
Cap. Flow %
4.75%
Top 10 Hldgs %
30.91%
Holding
4,786
New
852
Increased
1,597
Reduced
1,330
Closed
889

Sector Composition

Rank Sector Weight
1 Technology 7.61%
2 Financials 6.35%
3 Industrials 4.92%
4 Healthcare 4.88%
5 Consumer Discretionary 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRCA icon
3326
Verrica Pharmaceuticals
VRCA
$87.3M
$3K ﹤0.01%
25
-68
-73% -$7.84K
VYMI icon
3327
Vanguard International High Dividend Yield ETF
VYMI
$21.3B
$3K ﹤0.01%
44
-9
-17% -$541
XT icon
3328
iShares Future Exponential Technologies ETF
XT
$3.97B
$3K ﹤0.01%
78
-855
-92% -$31.1K
AIFU
3329
AIFU Inc
AIFU
$221M
-14
Closed -$138K
BACK
3330
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
$3K ﹤0.01%
+17
New +$1.92K
PMD
3331
DELISTED
Psychemedics Corporation
PMD
$3K ﹤0.01%
245
-44
-15% -$756
EVA
3332
DELISTED
Enviva Inc.
EVA
$3K ﹤0.01%
+100
New +$2.98K
EGIO
3333
DELISTED
Edgio, Inc. Common Stock
EGIO
$3K ﹤0.01%
+25
New +$2.9K
CMLS
3334
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$3K ﹤0.01%
141
-3,755
-96% -$57.7K
SCTL
3335
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$3K ﹤0.01%
624
+189
+43% +$1.4K
SRT
3336
DELISTED
Startek Inc.
SRT
$3K ﹤0.01%
385
-3,817
-91% -$28.5K
ONCT
3337
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$3K ﹤0.01%
19
-11
-37% -$1.64K
AVID
3338
DELISTED
Avid Technology Inc
AVID
$3K ﹤0.01%
355
-7,137
-95% -$37K
MAXR
3339
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$3K ﹤0.01%
576
+57
+11% +$335
CNCE
3340
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$3K ﹤0.01%
288
-635
-69% -$9.36K
OIIM
3341
DELISTED
02Micro International
OIIM
$3K ﹤0.01%
1,630
+266
+20% +$433
IBMK
3342
DELISTED
iShares iBonds Dec 2022 Term Muni Bond ETF
IBMK
$3K ﹤0.01%
100
AERI
3343
DELISTED
Aerie Pharmaceuticals
AERI
$3K ﹤0.01%
+60
New +$2.64K
AMPE
3344
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$3K ﹤0.01%
19
-25
-57% -$4.28K
EPZM
3345
DELISTED
Epizyme, Inc
EPZM
$3K ﹤0.01%
246
-1,454
-86% -$16.3K
HBMD
3346
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
$3K ﹤0.01%
+202
New +$2.84K
JRJC
3347
DELISTED
China Finance Online Co., Ltd.
JRJC
$3K ﹤0.01%
+187
New +$2.25K
ALSK
3348
DELISTED
Alaska Communications Systems
ALSK
$3K ﹤0.01%
1,792
-6,009
-77% -$10.9K
ANDAU
3349
DELISTED
Andina Acquisition Corp. III Unit
ANDAU
$3K ﹤0.01%
+256
New +$2.58K
FIT
3350
DELISTED
Fitbit, Inc. Class A common stock
FIT
$3K ﹤0.01%
475
-10,715
-96% -$65.1K

Similar funds

Tower Research Capital (TRC)'s Q1 2019 Portfolio in Review

As of Q1 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.65B, up 19% from $1.39B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Tower Research Capital (TRC) deployed $78.3M of net new capital in Q1 2019, opening 852 new positions and adding to 1,597 existing holdings. Its largest new stake was iShares MSCI USA Momentum Factor ETF: 56,999 shares worth $6.39M.

By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $94.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2019 buy was iShares MSCI USA Momentum Factor ETF: 56,999 shares worth $6.39M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2019, an estimated $312M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2019 reduction was iShares Russell 2000 ETF, cutting an estimated $94.8M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q1 2019, selling an estimated $6.12M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 31% of its $1.65B portfolio in Q1 2019.
  • Tower Research Capital (TRC) opened 852 new positions and closed 889 in Q1 2019.
  • Tower Research Capital (TRC)'s portfolio value rose 19% quarter-over-quarter to $1.65B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2019, filed 14 May 2019.